Join to View Full Profile
200 Medical Center DrSuite 3-OHazard, KY 41701
Phone+1 606-439-2239
Fax+1 606-439-3096
Dr. Ghazal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStar Health Georgetown University/Washington Hospital CenterFellowship, Hematology and Medical Oncology, 1995 - 1996
George Washington UniversityFellowship, Hematology and Medical Oncology, 1992 - 1995
Sinai Hospital of BaltimoreResidency, Internal Medicine, 1989 - 1992
American University of Beirut Faculty of MedicineClass of 1989
Certifications & Licensure
KY State Medical License 1997 - 2026
GA State Medical License 1997 - 1999
DC State Medical License 1993 - 1998
MD State Medical License 1990 - 1998
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
Clinical Trials
- Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. Start of enrollment: 2003 Jan 01
- Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin Start of enrollment: 2011 Jan 16
- Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 02
Publications & Presentations
PubMed
- 10 citationsBreast Cancer in the United Arab Emirates.Humaid O Al-Shamsi, Nadia Abdelwahed, Aydah Al-Awadhi, Mohamed Albashir, Amin M Abyad
JCO Global Oncology. 2023-01-01 - 14 citationsManagement of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendationsDeborah Mukherji, Bassem Youssef, Christelle Dagher, Albert El-Hajj, Rami Nasr
World Journal of Urology. 2020-03-01 - 2 citationsEfficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemiaRalph V. Boccia, David H. Henry, Laura Belton, Chet Bohac, Hassan H. Ghazal
Cancer Medicine. 2016-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
